FAM228A
gene geneOn this page
Also known as FLJ30851
Summary
FAM228A (family with sequence similarity 228 member A, HGNC:34418) is a protein-coding gene on chromosome 2p23.3, encoding Protein FAM228A (Q86W67).
At a glance
- GWAS associations: 2
- Clinical variants (ClinVar): 30 total
- MANE Select transcript:
NM_001040710
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:34418 |
| Approved symbol | FAM228A |
| Name | family with sequence similarity 228 member A |
| Location | 2p23.3 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | FLJ30851 |
| Ensembl gene | ENSG00000186453 |
| Ensembl biotype | protein_coding |
| Entrez | 653140 |
Gene structure
Transcript identifiers
Ensembl transcripts: 5 — 4 protein_coding, 1 nonsense_mediated_decay
ENST00000295150, ENST00000415196, ENST00000432434, ENST00000456591, ENST00000965618
RefSeq mRNA: 1 — MANE Select: NM_001040710
NM_001040710
CCDS: CCDS42659
Canonical transcript exons
ENST00000295150 — 6 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001334872 | 24175053 | 24175174 |
| ENSE00001346865 | 24190412 | 24191698 |
| ENSE00003460257 | 24183285 | 24183372 |
| ENSE00003495154 | 24177802 | 24177870 |
| ENSE00003506185 | 24183495 | 24183645 |
| ENSE00003651002 | 24175467 | 24175573 |
Expression profiles
Bgee: expression breadth ubiquitous, 133 present calls, max score 95.83.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.4173 / max 100.5920, expressed in 140 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 19177 | 0.3063 | 108 |
| 19176 | 0.1109 | 59 |
Top tissues by expression
139 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| cerebellar vermis | UBERON:0004720 | 95.83 | gold quality |
| left testis | UBERON:0004533 | 92.48 | gold quality |
| right testis | UBERON:0004534 | 92.21 | gold quality |
| testis | UBERON:0000473 | 92.09 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 88.01 | gold quality |
| quadriceps femoris | UBERON:0001377 | 80.34 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 80.17 | gold quality |
| thymus | UBERON:0002370 | 75.36 | silver quality |
| mucosa of stomach | UBERON:0001199 | 71.02 | gold quality |
| descending thoracic aorta | UBERON:0002345 | 69.80 | gold quality |
| prefrontal cortex | UBERON:0000451 | 69.34 | gold quality |
| apex of heart | UBERON:0002098 | 68.45 | gold quality |
| cortical plate | UBERON:0005343 | 68.29 | gold quality |
| frontal cortex | UBERON:0001870 | 68.26 | gold quality |
| dorsolateral prefrontal cortex | UBERON:0009834 | 67.77 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 67.23 | gold quality |
| omental fat pad | UBERON:0010414 | 67.21 | gold quality |
| cerebral cortex | UBERON:0000956 | 67.16 | gold quality |
| thoracic aorta | UBERON:0001515 | 67.02 | gold quality |
| adipose tissue | UBERON:0001013 | 66.93 | gold quality |
| ascending aorta | UBERON:0001496 | 66.82 | gold quality |
| right frontal lobe | UBERON:0002810 | 66.82 | gold quality |
| subcutaneous adipose tissue | UBERON:0002190 | 66.69 | gold quality |
| superior frontal gyrus | UBERON:0002661 | 66.58 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 66.19 | gold quality |
| left coronary artery | UBERON:0001626 | 66.14 | gold quality |
| corpus callosum | UBERON:0002336 | 66.14 | gold quality |
| amygdala | UBERON:0001876 | 65.79 | gold quality |
| right atrium auricular region | UBERON:0006631 | 65.70 | gold quality |
| temporal lobe | UBERON:0001871 | 65.63 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 1.90 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
45 targeting FAM228A, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-6867-5P | 100.00 | 82.21 | 3464 |
| HSA-MIR-432-3P | 100.00 | 67.86 | 705 |
| HSA-MIR-6798-5P | 100.00 | 65.77 | 699 |
| HSA-MIR-9-5P | 100.00 | 72.28 | 2361 |
| HSA-MIR-5193 | 100.00 | 67.26 | 1744 |
| HSA-MIR-4534 | 99.99 | 66.58 | 1907 |
| HSA-MIR-1229-3P | 99.97 | 66.49 | 906 |
| HSA-MIR-493-5P | 99.96 | 72.47 | 2382 |
| HSA-MIR-4487 | 99.96 | 64.58 | 1252 |
| HSA-MIR-4802-3P | 99.72 | 70.13 | 1273 |
| HSA-MIR-4306 | 99.72 | 70.50 | 3630 |
| HSA-MIR-4470 | 99.66 | 69.35 | 1767 |
| HSA-MIR-3202 | 99.66 | 67.70 | 2737 |
| HSA-MIR-3685 | 99.62 | 68.83 | 1621 |
| HSA-MIR-1260A | 99.61 | 66.67 | 1098 |
| HSA-MIR-1260B | 99.61 | 66.67 | 1098 |
| HSA-MIR-12117 | 99.50 | 67.57 | 868 |
| HSA-MIR-513A-3P | 99.39 | 70.63 | 3620 |
| HSA-MIR-513C-3P | 99.39 | 70.63 | 3620 |
| HSA-MIR-3911 | 99.38 | 66.95 | 1087 |
| HSA-MIR-185-5P | 99.35 | 68.60 | 2497 |
| HSA-MIR-4644 | 99.35 | 69.12 | 2514 |
| HSA-MIR-3199 | 99.17 | 65.19 | 696 |
| HSA-MIR-3688-5P | 99.12 | 69.67 | 1091 |
| HSA-MIR-3606-3P | 99.11 | 69.84 | 3254 |
| HSA-MIR-3160-3P | 99.07 | 64.78 | 955 |
| HSA-MIR-140-3P | 99.04 | 67.69 | 1324 |
| HSA-MIR-155-3P | 99.03 | 67.99 | 924 |
| HSA-MIR-935 | 98.82 | 69.36 | 1072 |
| HSA-MIR-7113-3P | 98.75 | 65.71 | 1120 |
Cross-species orthologs
3 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | fam228a | ENSDARG00000042936 |
| mus_musculus | Fam228a | ENSMUSG00000079177 |
| rattus_norvegicus | Fam228a | ENSRNOG00000050114 |
Paralogs (1): FAM228B (ENSG00000219626)
Protein
Protein identifiers
Protein FAM228A — Q86W67 (reviewed: Q86W67)
All UniProt accessions (4): F2Z3J0, H7C3M9, Q86W67, H7C4B8
UniProt curated annotations — full annotation on UniProt →
Similarity. Belongs to the FAM228 family.
RefSeq proteins (1): NP_001035800* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR040046 | FAM228 | Family |
UniProt features (2 total): chain 1, sequence variant 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q86W67-F1 | 63.60 | 0.00 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 20 (showing top):
CATTTCA_MIR203, BRUINS_UVC_RESPONSE_EARLY_LATE, GLI1_TARGET_GENES, MIR6867_5P, MIR493_5P, MIR3685, MIR4802_3P, GSE10273_HIGH_IL7_VS_HIGH_IL7_AND_IRF4_IN_IRF4_8_NULL_PRE_BCELL_DN, MIR12117, MIR4330, chr2p23, DESCARTES_FETAL_PLACENTA_SMOOTH_MUSCLE_CELLS, DNMT3A_TARGET_GENES, GSE29615_DAY3_VS_DAY7_LAIV_FLU_VACCINE_PBMC_UP, GSE1112_OT1_CD8AB_VS_HY_CD8AA_THYMOCYTE_RTOC_CULTURE_UP
GO Biological Process (0):
GO Molecular Function (1): protein binding (GO:0005515)
GO Cellular Component (0):
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| binding | 1 |
Protein interactions and networks
STRING
164 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| FAM228A | SPIN3 | Q5JUX0 | 447 |
| FAM228A | TMEM71 | Q6P5X7 | 435 |
| FAM228A | ZGRF1 | Q86YA3 | 431 |
| FAM228A | RFX8 | Q6ZV50 | 430 |
| FAM228A | CCDC32 | Q9BV29 | 419 |
| FAM228A | GDPD4 | Q6W3E5 | 418 |
| FAM228A | SLC25A47 | Q6Q0C1 | 417 |
| FAM228A | FAM174B | Q3ZCQ3 | 400 |
| FAM228A | ZNF101 | Q8IZC7 | 400 |
| FAM228A | SPATA17 | Q96L03 | 397 |
| FAM228A | GSC | P56915 | 370 |
| FAM228A | PPP1R3G | B7ZBB8 | 370 |
| FAM228A | VSTM1 | Q6UX27 | 370 |
| FAM228A | ADAM21 | Q9UKJ8 | 370 |
| FAM228A | TOR3A | Q9H497 | 369 |
IntAct
57 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| FAM228A | IFNA21 | psi-mi:“MI:0915”(physical association) | 0.590 |
| CDKN2D | FAM228A | psi-mi:“MI:0915”(physical association) | 0.560 |
| PLEKHA7 | FAM228A | psi-mi:“MI:0915”(physical association) | 0.560 |
| CCDC57 | FAM228A | psi-mi:“MI:0915”(physical association) | 0.560 |
| SPANXN3 | FAM228A | psi-mi:“MI:0915”(physical association) | 0.560 |
| GYS1 | FAM228A | psi-mi:“MI:0915”(physical association) | 0.560 |
| LMO4 | FAM228A | psi-mi:“MI:0915”(physical association) | 0.560 |
| MLH1 | FAM228A | psi-mi:“MI:0915”(physical association) | 0.560 |
| HSF2BP | FAM228A | psi-mi:“MI:0915”(physical association) | 0.560 |
| FAM228A | SCNM1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| FAM228A | FAM90A1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF76 | FAM228A | psi-mi:“MI:0915”(physical association) | 0.560 |
| LMO2 | FAM228A | psi-mi:“MI:0915”(physical association) | 0.560 |
| FAM228A | ENKD1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| FAM228A | EAF1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| BYSL | FAM228A | psi-mi:“MI:0915”(physical association) | 0.560 |
| SAT1 | FAM228A | psi-mi:“MI:0915”(physical association) | 0.560 |
| TNS2 | FAM228A | psi-mi:“MI:0915”(physical association) | 0.560 |
| COX5B | FAM228A | psi-mi:“MI:0915”(physical association) | 0.560 |
| GYS1 | FAM228A | psi-mi:“MI:0915”(physical association) | 0.000 |
| LMO4 | FAM228A | psi-mi:“MI:0915”(physical association) | 0.000 |
| MLH1 | FAM228A | psi-mi:“MI:0915”(physical association) | 0.000 |
| HSF2BP | FAM228A | psi-mi:“MI:0915”(physical association) | 0.000 |
| SCNM1 | FAM228A | psi-mi:“MI:0915”(physical association) | 0.000 |
| FAM90A1 | FAM228A | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (22): IFNA21 (Affinity Capture-MS), FAM228A (Two-hybrid), FAM228A (Two-hybrid), FAM228A (Two-hybrid), FAM228A (Two-hybrid), FAM228A (Two-hybrid), FAM228A (Two-hybrid), FAM228A (Two-hybrid), FAM228A (Two-hybrid), FAM228A (Two-hybrid), FAM228A (Two-hybrid), FAM228A (Two-hybrid), FAM228A (Two-hybrid), FAM228A (Two-hybrid), FAM228A (Two-hybrid)
ESM2 similar proteins: A0A1B0GUC4, A1STV0, A6NGY3, B8NI18, O54842, O84275, O89085, P03238, P03331, P05911, P11888, P26548, P26549, P27224, P56555, P87318, Q08270, Q08588, Q0P641, Q1KN10, Q1KN12, Q1KN16, Q1KN19, Q1KN23, Q1X6X9, Q1X6Y0, Q1X6Y1, Q1X6Y7, Q1X6Z0, Q1X6Z2, Q1X6Z3, Q1X700, Q1X711, Q2YDL7, Q5BL73, Q5RDL5, Q6AY31, Q6W0C5, Q84295, Q86W67
Diamond homologs: A6QQ68, P0C875, Q32KQ1, Q497Q6, Q5XIN5, Q86W67, Q8CDW1
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
30 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 25 |
| Likely benign | 3 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
957 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 2:24175532:T:G | donor_gain | 1.0000 |
| 2:24183362:GT:G | donor_gain | 1.0000 |
| 2:24183641:TACAG:T | donor_loss | 1.0000 |
| 2:24183642:ACAG:A | donor_loss | 1.0000 |
| 2:24183642:ACAGG:A | donor_loss | 1.0000 |
| 2:24183643:CAG:C | donor_loss | 1.0000 |
| 2:24183644:AGG:A | donor_loss | 1.0000 |
| 2:24183644:AGGTA:A | donor_loss | 1.0000 |
| 2:24183645:GG:G | donor_loss | 1.0000 |
| 2:24183646:G:GA | donor_loss | 1.0000 |
| 2:24183647:T:G | donor_loss | 1.0000 |
| 2:24183652:A:G | donor_gain | 1.0000 |
| 2:24190410:A:AG | acceptor_gain | 1.0000 |
| 2:24190411:G:GG | acceptor_gain | 1.0000 |
| 2:24175462:CTCA:C | acceptor_loss | 0.9900 |
| 2:24175463:TCA:T | acceptor_loss | 0.9900 |
| 2:24175464:CAGGG:C | acceptor_loss | 0.9900 |
| 2:24175465:A:AC | acceptor_loss | 0.9900 |
| 2:24175465:A:AG | acceptor_gain | 0.9900 |
| 2:24175465:AG:A | acceptor_gain | 0.9900 |
| 2:24175465:AGG:A | acceptor_gain | 0.9900 |
| 2:24175466:G:GG | acceptor_gain | 0.9900 |
| 2:24175466:GG:G | acceptor_gain | 0.9900 |
| 2:24175466:GGG:G | acceptor_gain | 0.9900 |
| 2:24175570:GGAG:G | donor_gain | 0.9900 |
| 2:24175571:G:GT | donor_gain | 0.9900 |
| 2:24175572:AGGT:A | donor_loss | 0.9900 |
| 2:24175573:GGT:G | donor_loss | 0.9900 |
| 2:24177796:TTTTA:T | acceptor_loss | 0.9900 |
| 2:24177797:TTTAG:T | acceptor_loss | 0.9900 |
AlphaMissense
1355 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 2:24190500:T:C | F164L | 0.910 |
| 2:24190502:C:A | F164L | 0.910 |
| 2:24190502:C:G | F164L | 0.910 |
| 2:24175517:T:C | F13L | 0.903 |
| 2:24175519:C:A | F13L | 0.903 |
| 2:24175519:C:G | F13L | 0.903 |
| 2:24177842:T:A | I45K | 0.882 |
| 2:24190488:T:C | F160L | 0.882 |
| 2:24190490:T:A | F160L | 0.882 |
| 2:24190490:T:G | F160L | 0.882 |
| 2:24175541:T:A | W21R | 0.876 |
| 2:24175541:T:C | W21R | 0.876 |
| 2:24175570:G:A | M30I | 0.856 |
| 2:24175570:G:C | M30I | 0.856 |
| 2:24175570:G:T | M30I | 0.856 |
| 2:24177842:T:C | I45T | 0.853 |
| 2:24177829:G:C | A41P | 0.836 |
| 2:24177809:C:A | A34D | 0.816 |
| 2:24177842:T:G | I45R | 0.814 |
| 2:24183300:T:C | F60L | 0.801 |
| 2:24183302:T:A | F60L | 0.801 |
| 2:24183302:T:G | F60L | 0.801 |
| 2:24177847:T:C | F47L | 0.795 |
| 2:24177849:T:A | F47L | 0.795 |
| 2:24177849:T:G | F47L | 0.795 |
| 2:24175543:G:C | W21C | 0.788 |
| 2:24175543:G:T | W21C | 0.788 |
| 2:24177806:T:C | L33S | 0.778 |
| 2:24177808:G:C | A34P | 0.774 |
| 2:24183569:T:C | F109L | 0.773 |
dbSNP variants (sampled 300 via entrez): RS1000857158 (2:24177568 G>A,T), RS1000882387 (2:24184441 T>C,G), RS1000913495 (2:24184228 A>G), RS1000915235 (2:24189847 C>G,T), RS1000971770 (2:24190007 C>G), RS1001101852 (2:24190084 C>T), RS1001400115 (2:24177457 A>G), RS1001469808 (2:24190340 C>A,G), RS1001885712 (2:24183184 T>A,C), RS1001919842 (2:24182899 C>T), RS1002070848 (2:24189202 C>T), RS1002140389 (2:24187697 G>A), RS1002372239 (2:24189465 T>A), RS1002484761 (2:24176111 A>C,G), RS1002656138 (2:24179593 A>G)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
2 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST005212_4 | Asthma | 2.000000e-07 |
| GCST90002407_215 | White blood cell count | 2.000000e-11 |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
7 total (human), top 7 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| bisphenol A | decreases methylation | 1 |
| ethyl-p-hydroxybenzoate | decreases expression | 1 |
| bisphenol S | decreases methylation | 1 |
| Diethylhexyl Phthalate | decreases expression | 1 |
| Drugs, Chinese Herbal | increases expression | 1 |
| Naphthoquinones | increases expression | 1 |
| Aflatoxin B1 | increases methylation | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.